Compliance4alllearning
Knowledge. Creativity. Performance
  • Category
    • Medical Device (ISO 13485)
    • Drugs / Biologics
    • FDA Compliance
    • Food & Beverages
    • Quality Management (ISO 9001)
    • OSHA Compliance
    • IT Security
    • Sox Compliance
    • Clinical Compliance
    • Auditing/Accounting & Tax
    • Banking & Insurance
    • Geology and Mining
    • Risk Management
    • Project Management
    • Intellectual Property Law
    • Excel Spreadsheet Techniques
    • FAA Compliance
    • Trade & Logistics
    • Retail
    • Environmental Compliance
Cart 0
Sign In Sign Up Cart 0
  • Home
  • About Us
  • Live Webinars
  • Recorded Webinars
  • Webinar Pack
  • Products/E-Books
  • Toll free: +1-800-447-9407
  • 10 per page
  • 20 per page
  • 30 per page
  • View All
  • 10 per page
  • 20 per page
  • 30 per page
  • View All
Recorded Webinars
Thomas E. Colonna

Introduction to Biomedical Software Regulation

The Food and Drug Administration (FDA) was not empowered by Congress to regulate medical devices until May 28, 1976 when the Medical Device Amendments were added to the Federal Food, Drug, and Cosmetic Act (FDCA).

Speaker: Thomas E. Colonna | View Anytime | Duration: 60 Minutes | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients.

Speaker: Thomas E. Colonna | View Anytime | Duration: 60 Minutes | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

The Dietary Supplement cGMP Rule (21 CFR part 111)

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Speaker: Thomas E. Colonna | View Anytime | Duration: 60 Minutes | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

Combination Products: A Regulatory Perspective

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

Introduction to FDA Regulation of Combination Products

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Combination Products

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA's Bioresearch Monitoring (BIMO) Program Biologic, Device, Animal Drug, and Food Areas

FDA's bioresearch monitoring program is a comprehensive, agency-wide program of on-site inspections and data audits designed to monitor all aspects of the conduct and reporting of FDA-regulated research. The BIMO Program was established in 1977 by a task force that included representatives from the drug, biologic, device, animal drug, and food areas.

Speaker: Thomas E. Colonna | View Anytime | Duration: 60 Minutes | Price: ¤190.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤137.00 | View Details
Thomas E. Colonna

FDA Regulation of Combination Products

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤138.00 | View Details
Thomas E. Colonna

FDA Regulation of In Vitro Diagnostics

In vitro diagnostic devices, or IVDs, are assays designed to test body fluids for the presence of any substance of interest to researchers, clinicians, and healthcare providers. IVDs can be used to detect hormones or antibodies, viruses or expressed cancer genes, bacteria or bacterial resistance to antibiotics, and beyond. The Food and Drug Administration (FDA) has created a flexible, yet sometimes confusing, approach to IVD regulation.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤134.00 | View Details
Thomas E. Colonna

Fundamentals on FDA Regulations of Bioresearch Monitoring

FDA's bioresearch monitoring program is a comprehensive, agency-wide program of on-site inspections and data audits designed to monitor all aspects of the conduct and reporting of FDA-regulated research. The BIMO Program was established in 1977 by a task force that included representatives from the drug, biologic, device, animal drug, and food areas.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤189.00 | View Details
Thomas E. Colonna

FDA Regulation of Medical Device Software

The Food and Drug Administration (FDA) was not empowered by Congress to regulate medical devices until May 28, 1976 when the Medical Device Amendments were added to the Federal Food, Drug, and Cosmetic Act (FDCA).

Speaker: Thomas E. Colonna | View Anytime | Price: ¤189.00 | View Details
Thomas E. Colonna

FDA Regulation of Dietary Supplements

FDA regulates both finished dietary supplement products and dietary ingredients. FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods and drug products.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤189.00 | View Details
Thomas E. Colonna

FDA Regulation of Combination Products

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤189.00 | View Details
Thomas E. Colonna

FDA Regulation of In Vitro Diagnostics

In vitro diagnostic devices, or IVDs, are assays designed to test body fluids for the presence of any substance of interest to researchers, clinicians, and healthcare providers. IVDs can be used to detect hormones or antibodies, viruses or expressed cancer genes, bacteria or bacterial resistance to antibiotics, and beyond. The Food and Drug Administration (FDA) has created a flexible, yet sometimes confusing, approach to IVD regulation.

Speaker: Thomas E. Colonna | View Anytime | Price: ¤189.00 | View Details
  • 10 per page
  • 20 per page
  • 30 per page
  • View All
  • 10 per page
  • 20 per page
  • 30 per page
  • View All
Compliance4alllearning
39658 Mission Boulevard, Fremont, CA 94539, USA.
+1-800-447-9407
Fax: 302 288 6884
support@compliance4alllearning.com

Links

About Us Contact Us Privacy Policy Refund Policy Terms & Conditions FAQ Support Featured Speakers Speaker Opportunity Suggest a Topic

Newsletter

Subscribe for Compliance Alerts Research Reports Absolutely Free

Safe & Secure


Safe & Secure

Copyright © 2025 compliance4alllearning. All rights reserved.